Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-25

Clinical Trial Update: Efficacy of Artemether-lumefantrine, Artesunate-amodiaquine and Dihydroartemisinin-piperaquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Malawi [NA]

View source ↗

Summary

This completed clinical trial in Malawi evaluates the efficacy of three artemisinin-based combination therapies—artemether-lumefantrine, artesunate-amodiaquine,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemether-lumefantrine (artemether and lumefantrine)
  • Artesunate-amodiaquine (artesunate-amodiaquine)
  • Dihydroartemisinin-piperaquine (dihydroartemisinin-piperaquine)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Malaria, Falciparum | NA | Status: COMPLETED